Cargando…

Alzheimer’s disease master regulators analysis: search for potential molecular targets and drug repositioning candidates

BACKGROUND: Alzheimer’s disease (AD) is a multifactorial and complex neuropathology that involves impairment of many intricate molecular mechanisms. Despite recent advances, AD pathophysiological characterization remains incomplete, which hampers the development of effective treatments. In fact, cur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vargas, D. M., De Bastiani, M. A., Zimmer, E. R., Klamt, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015462/ https://www.ncbi.nlm.nih.gov/pubmed/29935546 http://dx.doi.org/10.1186/s13195-018-0394-7

Ejemplares similares

Integrated transcriptomics reveals master regulators of lung adenocarcinoma and novel repositioning of drug candidates
por: De Bastiani, Marco Antônio, et al.
Publicado: (2019)

Master Regulators Connectivity Map: A Transcription Factors-Centered Approach to Drug Repositioning
por: De Bastiani, Marco A., et al.
Publicado: (2018)

A comparative study of COVID-19 transcriptional signatures between clinical samples and preclinical cell models in the search for disease master regulators and drug repositioning candidates
por: Chapola, Henrique, et al.
Publicado: (2023)

Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer’s disease patients
por: Bayraktar, Abdulahad, et al.
Publicado: (2023)

The Pharmacorank Search Tool for the Retrieval of Prioritized Protein Drug Targets and Drug Repositioning Candidates According to Selected Diseases
por: Gnilopyat, Sergey, et al.
Publicado: (2022)

Integrative Network-Based Analysis Reveals Gene Networks and Novel Drug Repositioning Candidates for Alzheimer Disease
por: Gerring, Zachary F., et al.
Publicado: (2021)

Drug repositioning in epilepsy reveals novel antiseizure candidates
por: Brueggeman, Leo, et al.
Publicado: (2018)

Plasminogen is a master regulator and a potential drug candidate for the healing of radiation wounds
por: Fallah, Mahsa, et al.
Publicado: (2020)

Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022)

Screening of Drug Repositioning Candidates for Castration Resistant Prostate Cancer
por: Kim, In-Wha, et al.
Publicado: (2019)

Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
por: Parisi, Daniele, et al.
Publicado: (2020)

Niacin as a drug repositioning candidate for hyperphosphatemia management in dialysis patients
por: Shin, Sooyoung, et al.
Publicado: (2014)

Potential for Drug Repositioning of Midazolam for Dentin Regeneration
por: Karakida, Takeo, et al.
Publicado: (2019)

Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer’s Disease
por: Corbett, Anne, et al.
Publicado: (2013)

β-Secretase-1: In Silico Drug Reposition for Alzheimer’s Disease
por: Galeana-Ascencio, Roberto A., et al.
Publicado: (2023)

Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19
por: Le, Brian L., et al.
Publicado: (2021)

Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19
por: Le, Brian L., et al.
Publicado: (2021)

Molecular interaction networks and drug development: Novel approach to drug target identification and drug repositioning
por: Loscalzo, Joseph
Publicado: (2022)

Opportunities for Web-based Drug Repositioning: Searching for Potential Antihypertensive Agents with Hypotension Adverse Events
por: Wang, Kejian, et al.
Publicado: (2016)

From drug repositioning to target repositioning: prediction of therapeutic targets using genetically perturbed transcriptomic signatures
por: Namba, Satoko, et al.
Publicado: (2022)

Hypericin as a potential drug for treating Alzheimer's disease and type 2 diabetes with a view to drug repositioning
por: Yuan, Xin, et al.
Publicado: (2023)

Drug Repositioning for Alzheimer’s Disease Based on Systematic ‘omics’ Data Mining
por: Zhang, Ming, et al.
Publicado: (2016)

Robust Sampling of Defective Pathways in Alzheimer’s Disease. Implications in Drug Repositioning
por: Fernández-Martínez, Juan Luis, et al.
Publicado: (2020)

A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer’s Disease
por: Lee, Soo Youn, et al.
Publicado: (2020)

Development of Pigmentation-Regulating Agents by Drug Repositioning
por: Jeong, Seo-Mi-Gon, et al.
Publicado: (2021)

DMAP: a connectivity map database to enable identification of novel drug repositioning candidates
por: Huang, Hui, et al.
Publicado: (2015)

Network Controllability-Based Prioritization of Candidates for SARS-CoV-2 Drug Repositioning
por: Ackerman, Emily E., et al.
Publicado: (2020)

An Integrated System Biology Approach Yields Drug Repositioning Candidates for the Treatment of Heart Failure
por: Yang, Guodong, et al.
Publicado: (2019)

Repositioning Drugs for Psychiatry
por: Akhondzadeh, Shahin
Publicado: (2020)

Drug Repositioning as a Therapeutic Strategy against Streptococcus pneumoniae: Cell Membrane as Potential Target
por: Ortiz-Miravalles, Laura, et al.
Publicado: (2023)

Large-scale Direct Targeting for Drug Repositioning and Discovery
por: Zheng, Chunli, et al.
Publicado: (2015)

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020)

Novel tacrine–benzofuran hybrids as potential multi-target drug candidates for the treatment of Alzheimer’s Disease
por: Fancellu, Gaia, et al.
Publicado: (2019)

In Silico Study towards Repositioning of FDA-Approved Drug Candidates for Anticoronaviral Therapy: Molecular Docking, Molecular Dynamics and Binding Free Energy Calculations
por: Qayed, Wesam S., et al.
Publicado: (2022)

Pathway-Based Drug Repositioning for Breast Cancer Molecular Subtypes
por: Mejía-Pedroza, Raúl A., et al.
Publicado: (2018)

New Drug Repositioning Candidates for T-ALL Identified Via Human/Murine Gene Signature Comparison
por: Bonnet, Raphaël, et al.
Publicado: (2020)

Targeting cancer stem cells with dietary phytochemical - Repositioned drug combinations
por: Chan, Marion M., et al.
Publicado: (2018)

Novel candidate drugs in anti-tumor necrosis factor refractory Crohn’s diseases: in silico study for drug repositioning
por: Kwak, Min Seob, et al.
Publicado: (2020)

An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
por: Ge, Yiyue, et al.
Publicado: (2021)

Lung adenocarcinoma-related target gene prediction and drug repositioning
por: Huang, Rui Xuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c49jvq1f2dveau6pt1ghg3u5ra